Michael Jantz
Overview
Explore the profile of Michael Jantz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mori V, Bates J, Jantz M, Mehta H, Kinsey C
Sci Rep
. 2022 Jan;
12(1):44.
PMID: 34996946
We recently developed a computational model of cisplatin pharmacodynamics in an endobronchial lung tumor following ultrasound-guided transbronchial needle injection (EBUS-TBNI). The model suggests that it is more efficacious to apportion...
2.
Altshuler E, Lowther G, Jantz M
J Investig Med High Impact Case Rep
. 2021 May;
9:23247096211014687.
PMID: 33969719
Primary pulmonary artery sarcomas (PPAS) are extremely rare tumors that are often mislabeled as pulmonary emboli (PE). PPAS usually involve the pulmonary trunk and are histologically classified as leiomyosarcoma, spindle...
3.
Zayed Y, Alzghoul B, Banifadel M, Venigandla H, Hyde R, Sutchu S, et al.
J Intensive Care Med
. 2021 Jan;
37(3):327-336.
PMID: 33511898
Background: There is a conflicting body of evidence regarding the benefit of vitamin C, thiamine, and hydrocortisone in combination as an adjunctive therapy for sepsis with or without septic shock....
4.
Kinsey C, San Jose Estepar R, Bates J, Cole B, Washko G, Jantz M, et al.
J Thorac Dis
. 2020 Nov;
12(9):4825-4832.
PMID: 33145055
Background: Endobronchial ultrasound-guided transbronchial needle injection of cisplatin (EBUS-TBNI cisplatin) is a therapeutic option for patients with recurrent lung cancer. However, the tumor characteristics that influence the distribution of the...
5.
Kheir F, Thakore S, Mehta H, Jantz M, Parikh M, Chee A, et al.
Ann Am Thorac Soc
. 2020 May;
17(8):958-964.
PMID: 32421353
Pleural infection is frequently encountered in clinical practice and is associated with high morbidity and mortality. Limited evidence exists regarding the optimal treatment. Although both early medical thoracoscopy (MT) and...
6.
Gando S, Labarca G, Majid A, Folch E, Mehta H, Jantz M, et al.
Rev Med Chil
. 2020 Mar;
147(10):1315-1322.
PMID: 32186640
Tridimensional printing is becoming relevant in medicine, specially in surgical and interventional specialties. We review the technical aspects and clinical application of airway tridimensional printing. Using this technique, simulation models...
7.
Kellish P, Shabashvili D, Rahman M, Nawab A, Guijarro M, Zhang M, et al.
J Clin Invest
. 2019 Apr;
129(6):2279-2292.
PMID: 31033480
Oncolytic virotherapy has been proposed as an ablative and immunostimulatory treatment strategy for solid tumors that are resistant to immunotherapy alone; however, there is a need to optimize host immune...
8.
Slebos D, Cicenia J, Sciurba F, Criner G, Hartman J, Garner J, et al.
Chest
. 2019 Feb;
155(5):928-937.
PMID: 30797746
Background: The Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) trial reported improvements in quality of life, pulmonary function, and exercise performance following endobronchial coil treatment. Objectives: The...
9.
Labarca G, Folch E, Jantz M, Mehta H, Majid A, Fernandez-Bussy S
Ann Am Thorac Soc
. 2018 Jul;
15(10):1205-1216.
PMID: 30011388
Rationale: Endobronchial ultrasound and transbronchial needle aspiration (EBUS-TBNA) are commonly used for the diagnosis and mediastinal staging of lung cancer. Molecular markers are becoming increasingly important in patients with lung...
10.
Fernandez-Bussy S, Labarca G, Vial M, Soto R, Mehta H, Jantz M, et al.
Am J Respir Crit Care Med
. 2017 Oct;
197(4):539-541.
PMID: 28968150
No abstract available.